Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022)

Cartesian Therapeutics (RNAC) has disclosed Change in Taxes for 2 consecutive years, with -$321000.0 as the latest value for Q3 2022.

  • Quarterly Change in Taxes fell 102.03% to -$321000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$321000.0 through Jun 2023, down 200.0% year-over-year, with the annual reading at -$601000.0 for FY2022, 200.0% down from the prior year.
  • Change in Taxes for Q3 2022 was -$321000.0 at Cartesian Therapeutics, down from $1000.0 in the prior quarter.
  • The five-year high for Change in Taxes was $15.8 million in Q3 2021, with the low at -$15.2 million in Q4 2021.